Tyrosinemia, Type II: Clinical Trials

2 trials for Tyrosinemia, Type II, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Tyrosinemia, Type II: new trials by email Literature Review of Tyrosinemia, Type II trials Research Report on Tyrosinemia, Type II

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies
Zero minis (range of protein substitutes in tablet form) - Tyrosinemia, Type I, Tyrosinemia, Type II
UnknownmetaX Institut fuer Diatetik GmbH152024-04-012024-03-07
Evaluation of TYR Sphere
TYR sphere - Tyrosinemias, Alkaptonuria
Not applicableCompletedVitaflo International, Ltd182019-10-012024-02-16

Narrower conditions

Alkaptonuria (2)  ·  Tyrosinemias (2)  ·  Ketosis (1)  ·  Metabolic Diseases (1)

Broader conditions

Amino Acid Metabolism, Inborn Errors (2)  ·  Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Central Nervous System Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Metabolism, Inborn Errors (2)  ·  Nervous System Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Acid-Base Imbalance (1)  ·  Acidosis (1)  ·  Metabolic Diseases (1)

Sponsors

Vitaflo International, Ltd (1)  ·  metaX Institut fuer Diatetik GmbH (1)

Countries

United Kingdom (1)

Top investigators

Anita MacDonald (1)  ·  Anita MacDonald, Professor (1)